Search results
Results From The WOW.Com Content Network
The "Cole memo" followed a 2009 memorandum from Deputy Attorney General David W. Ogden directing U.S. Attorneys in the Western United States to "not focus federal resources in your States on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana". [6]
The "Mary Lou Eimer Criteria" were instrumental in the issuance of the Cole Memorandum, which has set federal guidelines over states with medical marijuana laws and has urged the federal government to reschedule marijuana to a Class IV or Class V controlled substance based on the results of the Quiggle Study. [citation needed]
The Federal Rules of Evidence began as rules proposed pursuant to a statutory grant of authority, the Rules Enabling Act, but were eventually enacted as statutory law. The United States Supreme Court circulated drafts of the FRE in 1969, 1971 and 1972, but Congress then exercised its power under the Rules Enabling Act to suspend implementation ...
The memo scaled back federal intervention in states that legalized marijuana, as long as they implemented “strong and effective regulatory and enforcement systems to control the cultivation ...
Senate Bill 3, the “Compassionate Care Act,” would legalize medical marijuana for people who have cancer, ALS, Parkinson’s disease, epilepsy and other ailments. Those do not include chronic ...
Cultivating, distributing and possessing marijuana violates federal drug laws. However, the recreational use of cannabis has been legalized in 23 states, three U.S. territories, and D.C. so far.
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
The Drug Enforcement Administration initiated a 2024 policy review to potentially reschedule marijuana as a Schedule III drug, amounting to "the agency's biggest policy change in more than 50 years". [4] Some hiring and retention policies in federal employment and the armed forces evolved during 2024.